Diabetic peripheral neuropathy among Saudi diabetic patients: A multicenter cross-sectional study at primary health care setting

Rayan Abdullah Sendi, Amani Mohammed Mahrus, Ruba Mohammed Saeed, Moneer Adnan Mohammed, Sami Abdo Radman Al-Dubai, Rayan Abdullah Sendi, Amani Mohammed Mahrus, Ruba Mohammed Saeed, Moneer Adnan Mohammed, Sami Abdo Radman Al-Dubai

Abstract

Background: Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes and is responsible for morbidity and disability among diabetic patients.

Objectives: The aim of this study was to assess the prevalence of painful DPN and its associated risk factors in patients with diabetes mellitus.

Materials and methods: A cross-sectional study was conducted among 430 diabetic patients attending primary healthcare centres (PHC) in AL Madinah city, Saudi Arabia. The validated Douleur Neuropathique-4 (DN4) questionnaire was used to identify the presence of painful DPN.

Results: The majority were female (54.7%) and had type 2 diabetes mellitus (74.9%). The prevalence of DPN was 30.1% in type 2 diabetic patients and 25.9% in type 1 diabetic patients with an overall prevalence of 29.1%. DPN was associated significantly with age, duration of diabetes milieus, uncontrolled A1c, and positive family history of diabetes mellitus (P < 0.05). All the investigated comorbidities were also associated significantly with DPN (P < 0.05).

Conclusions: The prevalence of DPN was 25.9% and was associated with age duration of DM and uncontrolled HbA1c. PHC physicians treating diabetes should be more aware of the importance of screening for DPN and the treatment plan.

Keywords: Diabetic peripheral neuropathy; glycaemic control; pain; primary care.

Conflict of interest statement

There is no conflicts of interest.

Copyright: © 2020 Journal of Family Medicine and Primary Care.

References

    1. Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5:41.
    1. Khlid Al A AA, Nisha S. Risk factors associated with diabetes mellitus in a Saudi Community: A cross-sectional study. Prim Health Care. 2017;7:2167–79.
    1. Wang DD, Bakhotmah BA, Hu FB, Alzahrani HA. Prevalence and correlates of diabetic peripheral neuropathy in a Saudi Arabic population: A cross-sectional study. PloS One. 2014;9:e106935.
    1. Chastain CA, Klopfenstein N, Serezani CH, Aronoff DM. A clinical review of diabetic foot infections. Clin Podiatric Med Surg. 2019;36:381–95.
    1. Al-Ayed MY, Ababneh M, Robert AA, Salman A, Al Saeed A, Al Dawish MA. Evaluation of risk factors associated with diabetic foot ulcers in Saudi Arabia. Curr Diabetes Rev. 2019;15:224–32.
    1. Algeffari MA. Painful diabetic peripheral neuropathy among Saudi diabetic patients is common but under-recognized: Multicentre cross-sectional study at primary health care setting. J Family Community Med. 2018;25:43–7.
    1. Khan AR, Lateef ZN, Fatima S, Al Yousuf SA, Afghan SZ, Al Marghani S. Prevalence of chronic complication among type 2 diabetics attending primary health care centres of Al Ahsa district of Saudi Arabia: A cross sectional survey. Glob J Health Sci. 2014;6:245.
    1. AlSidr KS, Alotaibi MA, Alotaibi SK, Alhammadi FA, Abdullah M, Alotaibi M, et al. Diabetic foot and its clinical characteristics among uncontrolled diabetic patients in Ad-Dawadmi General Hospital, Riyadh Province, KSA. Saudi J Biomed Res. 2019;4:248–53.
    1. Saad N, Elhadedy K, Ramadan N, Mohmady O, Farid M. The prevalence and risk categorization of diabetic foot complications in cohort group in, Beni Suif, Egypt. Life Sci J. 2013;3:933–42.
    1. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis. Ann Med. 2017;49:106–16.
    1. Shi H. A health needs assessment of adults with diabetic foot disease in the US. Diabetes & metabolic syndrome. Clin Res Rev. 2019;13:2152–7.
    1. Jeffcoate WJ. Charcot foot syndrome. Diabet Med. 2015;32:760–70.
    1. Hébert HL, Veluchamy A, Torrance N, Smith BH. Risk factors for neuropathic pain in diabetes mellitus. Pain. 2017;158:560.
    1. American Diabetes Association. 3. Prevention or delay of type 2 diabetes: Standards of medical care in diabetes-2019. Diabet Care. 2019;42(Suppl 1):S29.
    1. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) Pain. 2005;114:29–36.
    1. Harifi G, Ouilki I, El Bouchti I, Ait Ouazar M, Belkhou A, Younsi R, et al. Validity and reliability of the Arabic adapted version of the DN4 questionnaire (Douleur Neuropathique 4 Questions) for differential diagnosis of pain syndromes with a neuropathic or somatic component. Pain Pract. 2011;11:139–47.
    1. Levterova B, Naydenov V, Todorov P, Leterov G. Prevalence and impact of peripheral neuropathy on quality of life in patients with diabetes mellitus pilot study. Trakia J Sci. 2018;16:71–6.
    1. Halawa MR, Karawagh A, Zeidan A, Mahmoud AE, Sakr M, Hegazy A painful diabetic peripheral neuropathy study group. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia. Curr Med Res Opin. 2010;26:337–43.
    1. Jambart S, Ammache Z, Haddad F, Younes A, Hassoun A, Abdalla K, et al. Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. J Int Med Res. 2011;39:366–77.
    1. Li L, Chen J, Wang J, Cai D. Prevalence and risk factors of diabetic peripheral neuropathy in type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China. Prim Care Diabet. 2015;9:191–5.
    1. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabet Care. 1994;17:1281–9.
    1. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabet Care. 2011;34:2220–4.
    1. Popescu S, Timar B, Baderca F, Simu M, Diaconu L, Velea I, et al. Age as an independent factor for the development of neuropathy in diabetic patients. Clin Int Aging. 2016;11:313.
    1. Darivemula S, Nagoor K, Patan SK, Reddy NB, Deepthi CS, Chittooru CS. Prevalence and its associated determinants of Diabetic Peripheral Neuropathy (DPN) in individuals having type-2 diabetes mellitus in Rural South India. Indian J Community Med. 2019;44:88–91.
    1. Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J. 2001;77:399–402.
    1. Mythili A, Kumar KD, Subrahmanyam KA, Venkateswarlu K, Butchi RG. A comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy. Int J Diabet Dev Ctries. 2010;30:43–8.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner